PROGNOSTIC-SIGNIFICANCE OF HER-2/NEU ONCOPROTEIN EXPRESSION IN NODE-POSITIVE BREAST-CANCER

被引：0
|
作者：
TETU, B
BRISSON, J
POTVIN, D
MARTEL, D
机构：
[1] UNIV LAVAL,CTR RECH CANC,DEPT PATHOL,QUEBEC CITY G1K 7P4,QUEBEC,CANADA
[2] UNIV LAVAL,RECH EPIDEMIOL GRP,QUEBEC CITY G1K 7P4,QUEBEC,CANADA
来源：
LABORATORY INVESTIGATION | 1993年 / 68卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A20 / A20
页数：1
相关论文
共 50 条
  • [1] PROGNOSTIC-SIGNIFICANCE OF HER-2/NEU ONCOPROTEIN EXPRESSION IN NODE-POSITIVE BREAST-CANCER - THE INFLUENCE OF THE PATTERN OF IMMUNOSTAINING AND ADJUVANT THERAPY
    TETU, B
    BRISSON, J
    CANCER, 1994, 73 (09) : 2359 - 2365
  • [2] HER-2/NEU ONCOPROTEIN AS A PROGNOSTIC FACTOR IN BREAST-CANCER
    TOIKKANEN, S
    JOENSUU, H
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (11) : 1817 - 1817
  • [3] HER-2/NEU AMPLIFICATION PREDICTS POOR SURVIVAL IN NODE-POSITIVE BREAST-CANCER
    BORG, A
    TANDON, AK
    SIGURDSSON, H
    CLARK, GM
    FERNO, M
    FUQUA, SAW
    KILLANDER, D
    MCGUIRE, WL
    CANCER RESEARCH, 1990, 50 (14) : 4332 - 4337
  • [4] PROGNOSTIC-SIGNIFICANCE OF HER-2 ONCOPROTEIN EXPRESSION IN BREAST-CANCER - A 30-YEAR FOLLOW-UP
    TOIKKANEN, S
    HELIN, H
    ISOLA, J
    JOENSUU, H
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (07) : 1044 - 1048
  • [5] HER-2/NEU IN NODE-NEGATIVE BREAST-CANCER - PROGNOSTIC-SIGNIFICANCE OF OVEREXPRESSION INFLUENCED BY THE PRESENCE OF INSITU CARCINOMA
    ALLRED, DC
    CLARK, GM
    TANDON, AK
    MOLINA, R
    TORMEY, DC
    OSBORNE, CK
    GILCHRIST, KW
    MANSOUR, EG
    ABELOFF, M
    EUDEY, L
    MCGUIRE, WL
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (04) : 599 - 605
  • [6] HER-2/NEU ONCOGENE AS A PROGNOSTIC FACTOR IN NODE NEGATIVE BREAST-CANCER
    PATERSON, AHG
    FOURNEY, RM
    DIETRICH, KD
    DANYLUK, J
    JAMIL, N
    LEES, AW
    KRAUSE, B
    MCEWAN, A
    LUKKA, H
    HANSON, J
    MCBLAIN, WH
    WILLAN, B
    SLAMON, DJ
    PATERSON, MC
    BREAST CANCER RESEARCH AND TREATMENT, 1988, 12 (01) : 109 - 109
  • [7] PROGNOSTIC-SIGNIFICANCE OF HER-2-NEU EXPRESSION IN BREAST-CANCER AND ITS RELATIONSHIP TO OTHER PROGNOSTIC FACTORS
    RILKE, F
    COLNAGHI, MI
    CASCINELLI, N
    ANDREOLA, S
    BALDINI, MT
    BUFALINO, R
    DELLAPORTA, G
    MENARD, S
    PIEROTTI, MA
    TESTORI, A
    INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (01) : 44 - 49
  • [8] THE RELATIVE PROGNOSTIC-SIGNIFICANCE OF TOTAL CATHEPSIN-D AND HER-2/NEU ONCOGENE AMPLIFICATION IN BREAST-CANCER
    SESHADRI, R
    HORSFALL, DJ
    FIRGAIRA, F
    MCCAUL, K
    SETLUR, V
    CHALMERS, AH
    YEO, R
    INGRAM, D
    DAWKINS, H
    HAHNEL, R
    ALLEN, DM
    BEARD, D
    BRITTENJONES, R
    BLACK, R
    BISWAS, B
    BRIDGEWATER, FHG
    BURKE, AM
    BUTCHER, CJ
    CARRANGIS, H
    CARTER, ML
    COX, JST
    DONOFRIO, GMD
    DEVITT, P
    FLETCHER, I
    GALLERY, R
    GAME, P
    GLYNN, PJ
    GILL, PG
    GUERRIERO, R
    GUE, S
    HAMILTON, DW
    HOFFMANN, CEJ
    HOARE, L
    HUNTER, R
    HUMENIUK, V
    JANSEN, TR
    JOHNSON, R
    JURY, RP
    KING, J
    KING, EPJ
    KIROFF, G
    LANDY, M
    LEONG, P
    MALYCHA, P
    MCINTOSH, NA
    MCLEAY, WRB
    MILL, JCD
    NATAR, G
    NETTLEFORD, J
    NEILD, A
    INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (01) : 61 - 65
  • [9] Prognostic significance of immunohistochemical expression of the HER-2/neu oncoprotein in bone metastatic prostate cancer
    Nishio, Yoshitaka
    Yamada, Yoshiaki
    Kokubo, Hiroto
    Nakamura, Kogenta
    Aoki, Shigeyuki
    Taki, Tomohiro
    Honda, Nobuaki
    Nakagawa, Atsuko
    Saga, Shinsuke
    Hara, Kazuo
    UROLOGY, 2006, 68 (01) : 110 - 115
  • [10] Prognostic value of HER-23/neu and p53 expression in node-positive breast cancer.: HER-2/neu effect on adjuvant tamoxifen treatment
    Climent, MA
    Seguí, MA
    Peiró, G
    Molina, R
    Lerma, E
    Ojeda, B
    López-López, JJ
    Alonso, C
    BREAST, 2001, 10 (01): : 67 - 77
12345